Protocol Summaries: ibandronate
| GSK Study ID |
Phase | Title | Status |
|---|---|---|---|
| BON105960 | Phase 3 | A parallel, placebo-controlled, randomized (2:1) double-blind study of one year duration to assess the effect of oral ibandronate 150 mg given once-monthly versus placebo on LS BMD in men with osteoporosis. | Active, not recruiting |